Navigation Links
Sinovac Reports Unaudited Full Year 2008 and Fourth Quarter Financial Results
Date:4/9/2009

nalysis and preparing the summary report.

In January 2009, the Company's wholly owned subsidiary, Tangshan Yian Biological Engineering Co., Ltd, obtained approval from China's Ministry of Agriculture to conduct field trials of its internally developed inactivated animal rabies vaccine, enabling the Company to enter the veterinary vaccine market in China with a high quality domestically-produced vaccine. Sinovac anticipates that the field trials will take approximately nine months to complete and that the vaccine will be launched in China's veterinary market in 2010.

As reported by media sources in February 2009, the State Food and Drug Administration (SFDA) completed a site inspection of Sinovac in conjunction of the government stockpiling program for Panflu, the pandemic influenza vaccine for which Sinovac holds manufacturing rights, to protect China's residents if an outbreak of human bird flu should occur. The production of the H5N1 vaccine for stockpiling is progressing on schedule.

In March 2009, Sinovac received GMP certification from the SFDA for its new filling and packaging production facility. With the receipt of the GMP certification, Sinovac's annual production capacity increased to 20 million doses, and has the potential to double to 40 million doses. This production milestone ensures that Sinovac can fully meet increasing market demand and potential production increases for currently commercialized products, such as Healive, Bilive and Anflu. The filling and packaging production plant also has the capabilities to fill and package Panflu, in support of the government stockpiling program, as well as products currently in Sinovac's development pipeline upon future launch following regulatory approval.

In 2008, Sinovac initiated the development program of a vaccine against EV 71. Development is progressing on schedule and good achievements have been made to date. The findi
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Sinovac Announces Postponement of Annual General Meeting
2. Sinovac Requests Extension for Annual Shareholders Meeting
3. Sinovac Reports Top-Line Preliminary Phase II Results of Pandemic Influenza (H5N1) Whole Viron Vaccine
4. Sinovac Closes $9.75 Million Private Placement
5. Sinovac Biotech Ltd. Schedules 2007 Annual Meeting of Shareholders
6. Sinovac Announces Adjournment of Annual General Meeting
7. Sinovac to Host Conference Call to Report Fourth Quarter and Full Year 2007 Financial Results
8. Sinovac Reports Fourth Quarter and Full Year 2007 Financial Results
9. Sinovac Biotech Holds Annual General Meeting
10. Sinovac to Present at the Brean Murray, Carret & Co. All-Cap All-China Conference and the Roth China Discovery Tour 2008
11. Sinovac Receives RMB 20 Million Purchase Order for Healive from Chinas Ministry of Health to Vaccinate Earthquake Victims
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... device," Nobel laureate Herbert Kroemer famously observed, referring ... the junctures where layers of different materials meet. ... between layers of metal oxides are becoming increasingly ... spintronics, high-temperature superconductors, ferroelectrics and multiferroics. Realizing the ...
(Date:1/15/2014)... 15, 2014 Look inside the new ... for the lab, from fluid handling to instruments to ... ship when you order. , Preferred Solutions features ... from the L/S® model for precise flow control and ...
(Date:1/15/2014)... (PRWEB) January 15, 2014 This webinar ... nonclinical and clinical safety assessment in biosimilars. , Regulatory ... for biosimilar drug development, however the complex nature of ... quality, safety and efficacy extremely challenging. Based on the ...
(Date:1/15/2014)... The Microcompetition with Foreign DNA theory explains how latent viruses ... is the Epstein Barr Virus (EBV), and one of these ... chronic inflammatory disease that destroys the body’s joints. As predicted ... high concentrations of EBV DNA in their bodies (1). ...
Breaking Biology Technology:A deeper look at interfaces 2Cole-Parmer Begins 2014 with the Release of Preferred Solutions 2Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 2Study: Rheumatoid Arthritis (RA) Patients Have EBV; The CBCD Says this is Consistent with Microcompetition 3
... , , , , , ... for examining , regulatory promoter and enhancer sequences ... cases, the element under investigation (promoter, enhancer) is cloned , ... subsequently , used to transfect cells. Quantification of ...
... , , , , , ... , , , , ... is an essential step in some of the most innovative , ... the cloning of mammals, and vaccination against cancer. Compared to the , ...
... , , , Note: Genomic DNA is fragile. ... Use suitable large-bore pipet tips or equipment when , pipetting genomic ... Place a 1 cm tail sample into a ... be stored at 20C. To minimize possible cross-contamination, , ...
Cached Biology Technology:Genetic Reporter Systems 2Genetic Reporter Systems 3Genetic Reporter Systems 4Principles and applications of electrical cell fusion 2Principles and applications of electrical cell fusion 3Principles and applications of electrical cell fusion 4Principles and applications of electrical cell fusion 5Mouse Tail Genomic DNA Isolation Protocol(1) 2
(Date:7/10/2014)... everyday household items such as washing machines could hold ... new study has claimed., As part of an EPSRC ... including those from the University of Exeter, have shown ... replicated in the natural world to help restock declining ... in essence a built-in feedback control mechanism to maintain ...
(Date:7/10/2014)... Consuming a whole fresh avocado with either an ... A carotenoid (alpha- and beta-carotene) absorption and conversion of ... according to new research (1) published in ... Vitamin A is involved in reproductive health and growth ... and has antioxidant properties. Provitamin A carotenoids, like alpha- ...
(Date:7/10/2014)... 2014Women in the West African nation Burkina Faso ... option. Sayana Press has the potential to increase ... health system and in communities by combining a ... (depot medroxyprogesterone acetate)with the BD Uniject injection system. ... African countries expected to begin introducing Sayana Press ...
Breaking Biology News(10 mins):Feedback control could be key to robust conservation management 2New research: Fresh avocado enhances absorption of essential nutrients for healthy living 2Injectable contraceptive launched in Burkina Faso to expand choice and address unmet need 2Injectable contraceptive launched in Burkina Faso to expand choice and address unmet need 3
... Researchers at the University of Granada (UGR) have studied the ... known population of Polygala balansae in Europe, a ... which was previously thought to be exclusive to Morocco. The ... and included on the list of threatened species. In ...
... taking non-oral and oral hormonal contraceptives were at highest ... study of female German medical students published today in ... women taking non-hormonal contraceptives were at lowest risk for ... "Sexual problems can have a negative impact on both ...
... change is happening today, a Kansas State University professor ... forest and grassland ecosystems. Kendra McLauchlan, assistant professor ... Foundation CAREER Award to examine contrasts in vegetation history ... nitrogen cycling and other ecosystem properties. McLauchlan is the ...
Cached Biology News:Polygala balansae, a new bush to Europe, at risk of extinction in Spain 2Hormonal contraceptives associated with higher risk of female sexual dysfunction 2Hormonal contraceptives associated with higher risk of female sexual dysfunction 3K-State professor using NSF award to study the impact of nitrogen deposition on global change 2